SBRA logo

Sabra Health Care REIT Inc. (SBRA)

$20.43

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on SBRA

Market cap

$5.09B

EPS

0.64

P/E ratio

27.3

Price to sales

6.67

Dividend yield

5.874%

Beta

0.667679

Price on SBRA

Previous close

$19.93

Today's open

$19.92

Day's range

$19.87 - $20.53

52 week range

$15.75 - $20.70

Profile about SBRA

CEO

Richard K. Matros

Employees

50

Headquarters

Tustin, CA

Exchange

Nasdaq Global Select

Shares outstanding

249349673

Issue type

Real Estate Investment Trust

SBRA industries and sectors

Real Estate

REITs

News on SBRA

Sabra Health Care REIT, Inc. (SBRA) Q4 2025 Earnings Call Transcript

Sabra Health Care REIT, Inc. (SBRA) Q4 2025 Earnings Call Transcript

news source

Seeking Alpha • Feb 13, 2026

news preview

Sabra Health Care REIT, Inc. to Attend Citi's 2026 Global Property CEO Conference

TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #CITI--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer; Michael Costa, the company's Chief Financial Officer; Darrin Smith, the company's Chief Investment Officer; and Lukas Hartwich, the company's Executive Vice President of Finance, will attend Citi's 2026 Global Property CEO Conference on March 1-4, 2026, at The Diplomat Beach Resort in Hollywood, Florida. About Sabra Sabra Health Care REI.

news source

Business Wire • Feb 13, 2026

news preview

Sabra Reports Fourth Quarter 2025 Results; Introduces 2026 Guidance

TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #4Q25--Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the fourth quarter of 2025. FOURTH QUARTER 2025 RESULTS AND RECENT EVENTS Results per diluted common share for the fourth quarter of 2025 were as follows: Net Income: $0.11 FFO: $0.36 Normalized FFO: $0.36 AFFO: $0.37 Normalized AFFO: $0.38 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.38x Senior Housing - Leased: 1.52x Beh.

news source

Business Wire • Feb 12, 2026

news preview

NAV Monitor: U.S. REITs End January At Median 16.2% Discount To Net Asset Value

NAV Monitor: U.S. REITs End January At Median 16.2% Discount To Net Asset Value

news source

Seeking Alpha • Feb 6, 2026

news preview

Sabra Health Care REIT, Inc. Announces Fourth Quarter 2025 Earnings Release Date and Conference Call; Declares Common Dividend

TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #4Q25--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2025 fourth quarter earnings release on February 12, 2026, after the close of trading. A conference call with a simultaneous webcast to discuss the 2025 fourth quarter results will be held on Friday, February 13 at 11:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference.

news source

Business Wire • Feb 2, 2026

news preview

Property Type Round-Up From REITWorld 2025

REITs are positioned for robust growth in 2026, driven by decelerating supply, disciplined capital allocation, and significant valuation discounts to NAV and private markets. Sector preferences favor Healthcare and Data Centers for durable growth, with Shopping Centers and select Residential REITs offering underappreciated upside and private capital interest. Strategic alternatives, buybacks, and targeted M&A are increasingly in focus, especially for deeply discounted names like CSR, WSR, COLD, and REXR.

news source

Seeking Alpha • Feb 3, 2026

news preview

Sabra Health Care REIT, Inc. Announces Tax Treatment of 2025 Distributions

TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #2025tax--Sabra Health Care REIT, Inc. (NASDAQ: SBRA) announced today the tax treatment for its 2025 distributions. The following table summarizes, for income tax purposes, the nature of cash distributions paid: Sabra Health Care REIT, Inc. Common Stock (CUSIP # 78573L106) Record Date Payable Date Distribution per Share   Total Ordinary Dividends   Non-Qualified Dividends   Qualified Dividends   Non-Dividend Distributions 02/14/2025 02/28/2025 $ 0.3000000   $ 0.2438846  .

news source

Business Wire • Jan 26, 2026

news preview

Sabra Health Care: A Compelling REIT Opportunity As SHOP Unlocks Hidden Value

Sabra Health Care REIT is rated Buy, with substantial upside driven by its accelerated transition to the SHOP operating model and attractive valuation. SBRA targets 40% SHOP portfolio exposure, expecting to exceed their up to $500M investment guidance, positioning for robust growth into 2026. Normalized AFFO guidance for 2025 is $1.495/share, with an 80% payout ratio supporting a 6.38% dividend yield and potential for future increases.

news source

Seeking Alpha • Jan 27, 2026

news preview

Dividend Income: Lanny's November 2025 Summary

In November, we (my wife and I) received a dividend income total of $1,489.90. Another $1,000+. Capital One Financial. After they acquired Discover, I was not sure what to expect.

news source

Seeking Alpha • Jan 12, 2026

news preview

Sabra Health Care REIT, Inc. Appoints Darrin Smith as Chief Investment Officer and Congratulates Talya Nevo-Hacohen on her Retirement

TUSTIN, Calif.--(BUSINESS WIRE)---- $CIO #CIO--Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) today announced that Darrin Smith has been appointed Sabra's Chief Investment Officer, Secretary and Executive Vice President, effective January 1, 2026. Mr. Smith succeeds Talya Nevo-Hacohen, Sabra's former Chief Investment Officer, Treasurer and Executive Vice President in connection with her retirement on December 31, 2025. From March 2020 until his appointment as Chief Investment Officer, Mr. Smith served.

news source

Business Wire • Jan 5, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Sabra Health Care REIT Inc.

Open an M1 investment account to buy and sell Sabra Health Care REIT Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in SBRA on M1